Internal Medicine, Infectious Disease · Bedford, TX
NPI
1891272027
Since 2018
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2636 Tibbets Dr Ste 110
Bedford, TX, 76022
Phone (817) 858-0065
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
967 services
Medicare patients, 2024
50
Average age 74
Drug cost, 2024
$114K
301 prescriptions
Company payments, 2024
$242
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel Gnanaprakasam was code 99232 (hospital e&m - subsequent), 50 times for 27 patients. In total Rachel Gnanaprakasam billed 967 services in 16 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 50 | 27 | $61.18 | $3,059 |
| 99233 Hospital E&M - Subsequent | Facility | 28 | 20 | $92.04 | $2,577 |
| 99214 Office E&M - Established | Office | 20 | 11 | $97.67 | $1,953 |
| 99223 Hospital E&M - Initial | Facility | 17 | 17 | $134.41 | $2,285 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $101.36 | $1,115 |
Medicare prescription drug claims, 2024
In 2024, the drug Rachel Gnanaprakasam prescribed most often to Medicare patients was Ceftriaxone (Ceftriaxone Sodium), with 50 prescriptions and refills. In total Rachel Gnanaprakasam wrote 301 Medicare prescriptions that cost $114K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ceftriaxone Ceftriaxone Sodium | 50 | 50 | 15 | $3,393 |
| Meropenem Generic | 24 | 24 | Under 11 | $4,887 |
| Doxycycline Hyclate Generic | 23 | 23 | 13 | $254 |
| Daptomycin Generic | 22 | 22 | Under 11 | $7,660 |
| Vancomycin Hcl Generic | 21 | 21 | Under 11 | $3,332 |
| Ertapenem Ertapenem Sodium | 18 | 18 | Under 11 | $6,616 |
| Cephalexin Generic | 14 | 20 | Under 11 | $270 |
| Levofloxacin Generic | 13 | 13 | Under 11 | $39.85 |
| Cefazolin Sodium Generic | 13 | 13 | Under 11 | $687 |
| Avycaz Ceftazidime/Avibactam | 11 | 11 | Under 11 | $71K |
Brand drugs: 30 claims; generic drugs: 271 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Rachel Gnanaprakasam $242 ($242 in general payments such as food, travel and fees) from 1 company. The largest payer was Paratek Pharmaceuticals, Inc. with $242.
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 3 | $242 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.